Forbes Kendall 4

What Happened

• Forbes Kendall, Executive Vice President, Sales & Operations of Guardian Pharmacy Services (GRDN), was granted a derivative award covering 50,000 shares on Feb 11, 2026. The Form 4 reports the acquisition price as $0.00, indicating an option/award rather than an open‑market purchase; no immediate cash changed hands and no shares were sold.

Key Details

• Transaction date: 2026-02-11; filing date: 2026-02-13 (filed within the typical 2‑business‑day window).
• Instrument: Derivative award (option) for 50,000 shares, acquisition price shown as $0.00.
• Vesting/Exercisability: Per footnote F1, the option vests and becomes exercisable in full on February 11, 2029.
• Shares owned after transaction: Not specified in the provided filing details.
• Filing timeliness: Appears timely (not marked late).

Context

• This was an option award (a form of compensation) with multi‑year vesting. Unlike an outright purchase, awards like this are common for executives and reflect compensation structure rather than an immediate bullish or bearish trading signal. The Form 4 does not show whether there is an exercise price or other terms beyond the vesting date, and no immediate sale or cashless exercise occurred.